Mikiko Mori

Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients

Mayumi Imahashi, Hirotaka Ode, Ayumi Kobayashi et al. · Scientific Reports · 2021 · 73 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Efficacy and safety of alogliptin added to insulin in Japanese patients with type 2 diabetes: a randomized, double-blind, 12-week, placebo-controlled trial followed by an open-label, long-term extension phase

Kohei Kaku, Mikiko Mori, Tatsuhiro Kanoo et al. · Expert Opinion on Pharmacotherapy · 2014 · 31 citations

Medicine, Endocrinology, Pharmacology +15

Nanopore Sequencing for Characterization of HIV-1 Recombinant Forms

Mikiko Mori, Hirotaka Ode, Mai Kubota et al. · Microbiology Spectrum · 2022 · 23 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist

Hironori Yuyama, Masanao Sanagi, Akiko Koakutsu et al. · European Journal of Pharmacology · 2003 · 19 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Molecular epidemiological features of SARS-CoV-2 in Japan, 2020–1

Hirotaka Ode, Yoshihiro Nakata, Mami Nagashima et al. · Virus Evolution · 2022 · 19 citations · Full text

Veterinary Medicine, Genetics, Infectious Diseases +17